In the US, the first person to make a vaccine against cancer

Creating a cure for cancer will be a huge breakthrough for the whole of mankind, but the disease is known to be much better to prevent than to cure. And recently, as reported by the Bloomberg publication, a group of scientists from the United States for the first time tested on humans personalized (that is created for a particular patient) a vaccine against cancer.

In the US, the first person to make a vaccine against cancer

The first person to receive a unique vaccine became Glenda Cleaver, and funding was provided as part of a startup Moderna Therapeutics. Scientists have sequenced the genome of the girl and found in it a number of mutations. These mutations, according to experts, in the future could cause the girl emergence of various forms of cancer. On the basis of the messenger RNA Glenda vaccine was created with the right "instructions" for the assembly of molecules that target the 20 proteins that are potentially dangerous. At this point the patient feels well, but scientists continue to observe Glenda. It is worth noting that this is not the first time the creation of such a vaccine. Back in 2010. Dendreon company has managed to create a similar drug, but it was extremely expensive to produce and failed to prove its effectiveness. Keep up with American researchers and their colleagues. For example, the German company BioNTech completed stage melanoma vaccine research and Gritstone Oncology Corporation plans to test polio vaccine against cancer as early as 2018. In addition, scientists from Neon Therapeutics will receive the first test results with regards to their own vaccine against bladder cancer, non-small cell lung cancer and melanoma as next year. Given the enormous interest of a number of companies to develop a vaccine, we want to believe that this medicine will still be created in the near future and will save several hundred lives.